99 related articles for article (PubMed ID: 30721582)
1. Molecular Epidemiological Study on Passive Smoking and Estrogen Receptor Expression in Never-smokers with Non-small Cell Lung Cancer.
Naoki Y; Kawaguchi T; Isa SI; Shimizu S; Tamiya A; Asai K; Kudoh S; Hirata K
Osaka City Med J; 2016 Dec; 62(2):77-84. PubMed ID: 30721582
[TBL] [Abstract][Full Text] [Related]
2. Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
Soo RA; Kubo A; Ando M; Kawaguchi T; Ahn MJ; Ou SI
Clin Lung Cancer; 2017 Sep; 18(5):535-542. PubMed ID: 28433570
[TBL] [Abstract][Full Text] [Related]
3. Long exposure of environmental tobacco smoke associated with activating EGFR mutations in never-smokers with non-small cell lung cancer.
Kawaguchi T; Ando M; Kubo A; Takada M; Atagi S; Okishio K; Asami K; Matsumura A; Tsujino K; Ignatius OS; Sasaki H
Clin Cancer Res; 2011 Jan; 17(1):39-45. PubMed ID: 21059816
[TBL] [Abstract][Full Text] [Related]
4. Specificities of lung adenocarcinoma in women who have never smoked.
Mazières J; Rouquette I; Lepage B; Milia J; Brouchet L; Guibert N; Beau-Faller M; Validire P; Hofman P; Fouret P
J Thorac Oncol; 2013 Jul; 8(7):923-9. PubMed ID: 23608817
[TBL] [Abstract][Full Text] [Related]
5. Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': epidemiology and clinical features.
Yano T; Haro A; Shikada Y; Maruyama R; Maehara Y
Int J Clin Oncol; 2011 Aug; 16(4):287-93. PubMed ID: 21562939
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation.
Raso MG; Behrens C; Herynk MH; Liu S; Prudkin L; Ozburn NC; Woods DM; Tang X; Mehran RJ; Moran C; Lee JJ; Wistuba II
Clin Cancer Res; 2009 Sep; 15(17):5359-68. PubMed ID: 19706809
[TBL] [Abstract][Full Text] [Related]
7. Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer.
Lee YJ; Cho BC; Jee SH; Moon JW; Kim SK; Chang J; Chung KY; Park IK; Choi SH; Kim JH
J Clin Oncol; 2010 Jan; 28(3):487-92. PubMed ID: 20008630
[TBL] [Abstract][Full Text] [Related]
8. Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07.
Viñolas N; Garrido P; Isla D; Provencio M; Majem M; Artal A; Carcereny E; Garcia Campelo R; Lianes P; De La Peñas R; Felip E
Cancer Invest; 2017 May; 35(5):358-365. PubMed ID: 28350480
[TBL] [Abstract][Full Text] [Related]
9. Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424).
Cheng TD; Darke AK; Redman MW; Zirpoli GR; Davis W; Payne Ondracek R; Bshara W; Omilian AR; Kratzke R; Reid ME; Molina JR; Kolesar JM; Chen Y; MacRae RM; Moon J; Mack P; Gandara DR; Kelly K; Santella RM; Albain KS; Ambrosone CB
J Natl Cancer Inst; 2018 Jul; 110(7):734-742. PubMed ID: 29346580
[TBL] [Abstract][Full Text] [Related]
10. Divergent epidermal growth factor receptor mutation patterns between smokers and non-smokers with lung adenocarcinoma.
Tseng JS; Wang CL; Yang TY; Chen CY; Yang CT; Chen KC; Hsu KH; Tsai CR; Chang GC
Lung Cancer; 2015 Dec; 90(3):472-6. PubMed ID: 26474957
[TBL] [Abstract][Full Text] [Related]
11. Multiple primary malignancies in patients with non-small cell lung cancer.
Fujita S; Masago K; Takeshita J; Togashi Y; Hata A; Kaji R; Kokubo M; Katakami N
Intern Med; 2015; 54(3):325-31. PubMed ID: 25748742
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?
Ou SH
J Clin Pathol; 2013 Oct; 66(10):839-46. PubMed ID: 23661716
[TBL] [Abstract][Full Text] [Related]
13. Steroid receptor and growth factor receptor expression in human nonsmall cell lung cancers using cells procured by laser-capture microdissection.
Kerr A; Eliason JF; Wittliff JL
Adv Exp Med Biol; 2008; 617():377-84. PubMed ID: 18497061
[TBL] [Abstract][Full Text] [Related]
14. Proportion and clinical features of never-smokers with non-small cell lung cancer.
Cho J; Choi SM; Lee J; Lee CH; Lee SM; Kim DW; Yim JJ; Kim YT; Yoo CG; Kim YW; Han SK; Park YS
Chin J Cancer; 2017 Feb; 36(1):20. PubMed ID: 28179026
[TBL] [Abstract][Full Text] [Related]
15. Association between hormone receptor expression and epidermal growth factor receptor mutation in patients operated on for non-small cell lung cancer.
Sun HB; Zheng Y; Ou W; Fang Q; Li P; Ye X; Zhang BB; Yang H; Wang SY
Ann Thorac Surg; 2011 May; 91(5):1562-7. PubMed ID: 21524465
[TBL] [Abstract][Full Text] [Related]
16. The genomic landscape of nonsmall cell lung carcinoma in never smokers.
Boeckx B; Shahi RB; Smeets D; De Brakeleer S; Decoster L; Van Brussel T; Galdermans D; Vercauter P; Decoster L; Alexander P; Berchem G; Ocak S; Vuylsteke P; Deschepper K; Lambrechts M; Cappoen N; Teugels E; Lambrechts D; De Greve J
Int J Cancer; 2020 Jun; 146(11):3207-3218. PubMed ID: 31745979
[TBL] [Abstract][Full Text] [Related]
17. Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
Kim HR; Shim HS; Chung JH; Lee YJ; Hong YK; Rha SY; Kim SH; Ha SJ; Kim SK; Chung KY; Soo R; Kim JH; Cho BC
Cancer; 2012 Feb; 118(3):729-39. PubMed ID: 21720997
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.
Kawai H; Ishii A; Washiya K; Konno T; Kon H; Yamaya C; Ono I; Minamiya Y; Ogawa J
Clin Cancer Res; 2005 Jul; 11(14):5084-9. PubMed ID: 16033821
[TBL] [Abstract][Full Text] [Related]
19. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
Lee KH; Min HS; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Heo DS; Bang YJ; Sung SW; Kim JH
Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700
[TBL] [Abstract][Full Text] [Related]
20. Expression of estrogen receptor beta predicts a clinical response and longer progression-free survival after treatment with EGFR-TKI for adenocarcinoma of the lung.
Nose N; Uramoto H; Iwata T; Hanagiri T; Yasumoto K
Lung Cancer; 2011 Mar; 71(3):350-5. PubMed ID: 20615575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]